Rezolute (RZLT) Shares Outstanding (Diluted Average) (2013 - 2026)

Rezolute's (RZLT) quarterly Shares Outstanding (Diluted Average) came in at $103.7 million in Q1 2026, up 48.1% year-on-year from $70.0 million in Q1 2025, and little changed quarter-over-quarter from $103.7 million in Q4 2025.

Rezolute (RZLT) Shares Outstanding (Diluted Average) (2013 - 2026) Analysis & Trends

Rezolute has disclosed Shares Outstanding (Diluted Average) across 9 years of filings, most recently posting $103.7 million for Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $103.7 million, up 48.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $103.7 million (up 48.1% YoY), and the FY2025 annual result was $76.0 million, up 47.67% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $103.7 million for Q1 2026 at Rezolute, roughly flat from $103.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $103.7 million in Q1 2026 to a low of $13.7 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $51.4 million (2023), against an average of $61.1 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) surged 493.54% in 2022 and grew 0.19% in 2024, its largest moves.
  • Rezolute's Shares Outstanding (Diluted Average) stood at $51.0 million in 2022, then rose by 0.86% to $51.4 million in 2023, then surged by 36.05% to $69.9 million in 2024, then soared by 48.25% to $103.7 million in 2025, then increased by 0.03% to $103.7 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $103.7 million (Q1 2026), $103.7 million (Q4 2025), and $103.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4,489.46 Bn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 810.00
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 118.76 Bn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 256.30 Mn
9 Abivax 94.37 Bn 94.37 Bn - 92.44 Mn
10 Rezolute 425.23 Mn 425.23 Mn - 103.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 103.71 Mn
Dec 31, 2025 103.69 Mn
Sep 30, 2025 103.42 Mn
Jun 30, 2025 76.00 Mn
Mar 31, 2025 70.03 Mn
Dec 31, 2024 69.94 Mn
Sep 30, 2024 69.74 Mn
Jun 30, 2024 51.47 Mn
Mar 31, 2024 51.21 Mn
Dec 31, 2023 51.41 Mn
Sep 30, 2023 51.41 Mn
Jun 30, 2023 51.19 Mn
Mar 31, 2023 51.11 Mn
Dec 31, 2022 50.97 Mn
Sep 30, 2022 50.53 Mn
Jun 30, 2022 19.49 Mn
Mar 31, 2022 13.75 Mn
Dec 31, 2021 15.68 Mn
Sep 30, 2021 8.51 Mn
Jun 30, 2021 7.67 Mn